No that's not quite right. The efficacy was tested in the validation trial, and this implementation study tested that when two different testers apply the same test to the same dementia patient they get the same result. The result was better for patients at rest (100% agreement) compared to while moving (repositioning or walking). All patients had moderate to severe dementia.
- Forums
- ASX - By Stock
- PCK
- Ann: Second Quarter Report FY 2016/17
Ann: Second Quarter Report FY 2016/17, page-32
-
- There are more pages in this discussion • 181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
|
|||||
Last
3.6¢ |
Change
0.004(12.5%) |
Mkt cap ! $58.88M |
Open | High | Low | Value | Volume |
3.3¢ | 3.6¢ | 3.3¢ | $67.31K | 1.930M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 74 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 74 | 0.036 |
2 | 149844 | 0.035 |
3 | 374813 | 0.034 |
1 | 30000 | 0.033 |
3 | 197812 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 220000 | 2 |
0.040 | 281700 | 5 |
0.045 | 218793 | 1 |
0.049 | 180000 | 1 |
0.050 | 14288 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |